Alliance Global lowered the firm's price target on Nano-X Imaging to $5 from $7 and keeps a Buy rating on the shares. The company reported Q4 results that were within the firm's expectations, with the main points of the print including that the quarter was in-line with AGP forecasts, management maintained 2026 revenue guidance, implying a significant upward breakout from current trends, and the company highlighting recent distribution agreements, the analyst tells investors in a research note. The firm added that it remains more conservative pending data points of execution.
